← Back to All Filings
Jazz Pharmaceuticals Director Files Form 144 Notice of Proposed Sale
Jazz Pharmaceuticals plc
$JAZZ144CIK: 0001232524
Subscribe to track JAZZ
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
📋 Form 144 Notice: Jazz Pharmaceuticals plc ($JAZZ) Insider: RIEDEL NORBERT G (Director) Proposed Transaction: Sale of 3,507 Common Shares (~$857,602.00) Approx. Sale Date: 2026-08-31 Broker: E*TRADE Financial Corporation Source of Shares: Restricted Stock Vesting (Acquired 08/28/2026)
Comprehensive Analysis
Insider Filing Analysis: Form 144 (Proposed Sale)
Summary
- Issuer: Jazz Pharmaceuticals plc (
JAZZ/ CIK:0001232524) - Insider: Norbert G. Riedel (Director / CIK:
0001161662) - Filing Date: August 31, 2026
- Proposed Sale Date: August 31, 2026
Transaction Details
- Securities to be Sold: 3,507 Common Shares
- Estimated Aggregate Market Value: $857,602.00 (~$244.54 per share)
- Broker: E*TRADE Financial Corporation
- Origin of Shares: Acquired via Restricted Stock Vesting on August 28, 2026, as compensation from the issuer.
- Past 3 Months Activity: No prior sales reported in the preceding 3 months.
Significance
- Trading Significance: Low
- Context: The proposed sale represents a modest volume (3,507 shares) relative to Jazz Pharmaceuticals' 64,914,577 shares outstanding. It originates directly from newly vested restricted stock units, reflecting standard liquidity management following equity compensation vesting.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.